2022
DOI: 10.1007/s00134-021-06611-y
|View full text |Cite
|
Sign up to set email alerts
|

One-year mortality after ICU admission due to COVID-19 infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
11
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(21 citation statements)
references
References 5 publications
5
11
2
Order By: Relevance
“…Tests are reported without correction for multiple comparisons RRT renal replacement therapy, ICU intensive care unit 1 n (%); median (IQR) 2 Pearson's chi-squared test; Wilcoxon rank sum test; Fisher's exact test…”
Section: Table 4 Outcomesmentioning
confidence: 99%
See 1 more Smart Citation
“…Tests are reported without correction for multiple comparisons RRT renal replacement therapy, ICU intensive care unit 1 n (%); median (IQR) 2 Pearson's chi-squared test; Wilcoxon rank sum test; Fisher's exact test…”
Section: Table 4 Outcomesmentioning
confidence: 99%
“…In the past 2 years, critical care services worldwide have admitted a large number of critically ill COVID-19 patients presenting with severe respiratory failure who often require prolonged treatment in the intensive care unit (ICU). Unfortunately, despite the support provided, mortality remains high, particularly in ventilated patients [2]. Although many groups and societies have studied diagnostic, therapeutic and prognostic aspects of COVID-19 in the critically ill, these studies were mostly limited to a group of hospitals or geographical areas, and very few reports offer a global perspective.…”
Section: Introductionmentioning
confidence: 99%
“…The automation of analysis allowed us to perform many sub-studies concurrently during the project. Nine of those were conducted through the automated analysis methodology, of which two have already been published 17 , 24 and another two are under review with a journal. The remaining five are currently being drafted.…”
Section: Resultsmentioning
confidence: 99%
“… 27 . In the overall population at 1 year follow-up, it was notable that the overall mortality of discharged patients was only 1%, 17 a striking finding given that patients with community acquired pneumonia suffer mortality rates as high as 30%. 28 Ongoing studies are considering the identification of clinical and biological predictors of long-term pulmonary sequelae.…”
Section: Discussionmentioning
confidence: 96%
“…Older age, high fever, comorbidities, neutrophilia, lymphocytopenia, elevated end organ-related indices (e.g., aspartate aminotransferase, urea, lactate dehydrogenase) and inflammatory biomarkers, and coagulation disorders were significantly associated with a higher risk of ARDS onset [30]. COVID-19-related may cause lung sequelae [31,32] in the long term; however, mortality rates have not been reported to significantly increase after discharge [33].…”
Section: Ards Due To Respiratory Infectionsmentioning
confidence: 99%